127 filings
8-K
IVVD
Invivyd Inc
31 May 24
Invivyd Announces the Appointment of Timothy Lee as Chief Commercial Officer
7:12am
8-K
IVVD
Invivyd Inc
22 May 24
Invivyd Elects Two New Independent Members to its Board of Directors
7:06am
S-8
IVVD
Invivyd Inc
9 May 24
Registration of securities for employees
4:32pm
10-Q
2024 Q1
IVVD
Invivyd Inc
Quarterly report
9 May 24
4:20pm
8-K
IVVD
Invivyd Inc
9 May 24
Invivyd Reports First Quarter 2024 Financial Results and Recent Business Highlights
4:08pm
8-K
p4aw5gyk kvscnm
7 May 24
Invivyd to Pursue Rapid Immunobridging Pathway to Potential EUA for Treatment of COVID-19
7:38am
EFFECT
js8on9b3t hkhl1cj
22 Apr 24
Notice of effectiveness
12:15am
ARS
jr00dfgjf1ueuae8
18 Apr 24
Annual report to shareholders
4:15pm
8-K
myn6j u1ee67bahim
12 Apr 24
Invivyd Announces CEO Transition
7:36am
8-K
rjtyvhhwef6
4 Apr 24
Invivyd Provides PEMGARDATM Launch Update and Announces 2024 Net Product
5:25pm
8-K
0dbjw
28 Mar 24
Invivyd Reports Full Year 2023 Financial Results and Recent Business Highlights
7:05am
8-K
t4tu8
22 Mar 24
Invivyd Announces FDA Authorization for Emergency Use of PEMGARDAâ„¢ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19
8:58pm
8-K
ps3w6b9yovfo588
9 Feb 24
Index to Consolidated Financial Statements
4:01pm
8-K
lfc6vs0bkq3t08
8 Jan 24
Other Events
7:12am
8-K
vm8ibnaiufvf9b984tf
3 Jan 24
Other Events
7:06am
8-K
a13qgvf
22 Dec 23
Entry into a Material Definitive Agreement
4:53pm
424B5
k7coabw 3c7i
22 Dec 23
Prospectus supplement for primary offering
4:51pm